Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Cecily, Quinn"'
Autor:
Mohamed Zaakouk, Cecily Quinn, Elena Provenzano, Clinton Boyd, Grace Callagy, Soha Elsheikh, Joe Flint, Rebecca Millican-Slater, Anu Gunavardhan, Yasmeen Mir, Purnima Makhija, Silvana Di Palma, Susan Pritchard, Bruce Tanchel, Emad Rakha, Nehal M. Atallah, Andrew H.S. Lee, Sarah Pinder, Abeer M. Shaaban
Publikováno v:
Breast, Vol 70, Iss , Pp 82-91 (2023)
Background: Recent clinical evidence showed that breast cancer with low HER2 expression levels responded to trastuzumab deruxtecan therapy. The HER2-low cancers comprise immunohistochemistry (IHC) score 1+ and 2+ ISH non-amplified tumours, currently
Externí odkaz:
https://doaj.org/article/464b369375de4cabbec57321f8b22a03
Autor:
Sergei Muratov, Carlos Canelo-Aybar, Jean-Eric Tarride, Pablo Alonso-Coello, Nadya Dimitrova, Bettina Borisch, Xavier Castells, Stephen W. Duffy, Patricia Fitzpatrick, Markus Follmann, Livia Giordano, Solveig Hofvind, Annette Lebeau, Cecily Quinn, Alberto Torresin, Claudia Vialli, Sabine Siesling, Antonio Ponti, Paolo Giorgi Rossi, Holger Schünemann, Lennarth Nyström, Mireille Broeders, On behalf of the ECIBC contributor group
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their accep
Externí odkaz:
https://doaj.org/article/5ccbe887c7ed475595c0ced2a33201e2
Autor:
Tejan Baldeh, Zuleika Saz-Parkinson, Paola Muti, Nancy Santesso, Gian Paolo Morgano, Wojtek Wiercioch, Robby Nieuwlaat, Axel Gräwingholt, Mireille Broeders, Stephen Duffy, Solveig Hofvind, Lennarth Nystrom, Lydia Ioannidou-Mouzaka, Sue Warman, Helen McGarrigle, Susan Knox, Patricia Fitzpatrick, Paolo Giorgi Rossi, Cecily Quinn, Bettina Borisch, Annette Lebeau, Chris de Wolf, Miranda Langendam, Thomas Piggott, Livia Giordano, Cary van Landsveld-Verhoeven, Jacques Bernier, Peter Rabe, Holger J. Schünemann
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-21 (2020)
Abstract Background During healthcare guideline development, panel members often have implicit, different definitions of health outcomes that can lead to misunderstandings about how important these outcomes are and how to balance benefits and harms.
Externí odkaz:
https://doaj.org/article/91e47e1a72b14fdcaba46383aa5abfa9
Autor:
Maria P. Foschini, Stefano Chillotti, Riccardo Ciudino, Viscardo P. Fabbri, Alberto Righi, Cecily Quinn
Publikováno v:
Diagnostic Histopathology. 28:142-148
Publikováno v:
Diagnostic Histopathology. 28:126-141
Autor:
Tetsunari Oyama, Cecily Quinn, Ian O. Ellis, Ayaka Katayama, Emad A. Rakha, Matthew Parkin, Takaaki Sano, Michael S. Toss
Publikováno v:
Histopathology. 80:515-528
Background Although evaluation of nuclear morphology plays a crucial role in the diagnosis and categorisation of breast lesions, the criteria used to assess nuclear atypia rely on the subjective evaluation of several features that may result in inter
Autor:
Emad A Rakha, Puay Hoon Tan, Cecily Quinn, Elena Provenzano, Abeer M Shaaban, Rahul Deb, Grace Callagy, Jane Starczynski, Andrew H S Lee, Ian O Ellis, Sarah E Pinder
Publikováno v:
Journal of clinical pathology.
The last UK breast cancer (BC) human epidermal growth factor receptor 2 (HER2) testing guideline recommendations were published in 2015. Since then, new data and therapeutic strategies have emerged. The American Society of Clinical Oncology (ASCO)/Co
Publikováno v:
HistopathologyReferences. 82(1)
Accurate pathological diagnosis is the cornerstone of optimal clinical management for patients with breast disease. As non-operative diagnosis has now become the standard of care, histopathologists encounter the daily challenge of making definitive d
Autor:
Ned Quirke, Carolyn Cullinane, Matthew Turk, Natasha Shafique, Denis Evoy, James Geraghty, Damian McCartan, Cecily Quinn, Janice Walsh, Enda McDermott, Claire Rutherford, Ruth Prichard
Publikováno v:
European Journal of Surgical Oncology. 49:e261
Publikováno v:
Histopathology. 79:465-479
Breast lesions with a prominent myoepithelial cell component constitute a heterogeneous group of benign and malignant neoplastic proliferations. These lesions are often dual epithelial-myoepithelial, but may be purely myoepithelial cell in nature. Be